EFFICACY AND SAFETY OF CILAZAPRIL IN HYPERTENSIVE PATIENTS WITH MODERATE TO SEVERE RENAL IMPAIRMENT

被引：0
|
作者：
CARLSEN, JE [1 ]
HANSEN, FM [1 ]
JENSEN, HA [1 ]
机构：
[1] HVIDOVRE UNIV HOSP,DEPT NEPHROL,DK-2650 HVIDOVRE,DENMARK
来源：
AMERICAN JOURNAL OF MEDICINE | 1989年 / 87卷 / 6B期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S79 / S82
页数：4
相关论文
共 50 条
  • [41] Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction
    Ito, Sadayoshi
    Nakura, Noriko
    Le Breton, Stephanie
    Keefe, Deborah
    HYPERTENSION RESEARCH, 2010, 33 (01) : 62 - 66
  • [42] Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction
    Sadayoshi Ito
    Noriko Nakura
    Stephanie Le Breton
    Deborah Keefe
    Hypertension Research, 2010, 33 : 62 - 66
  • [43] The Efficacy and Tolerability of Febuxostat in Hyperuricemic Patients with Severe Renal Impairment
    Oh, Ji Seon
    Choi, Seungwon
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [44] Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study
    Akira Maeyama
    Masakazu Kondo
    Hiroshi Harada
    Eisuke Shono
    Ryuji Nagamine
    Tomomi Tsuru
    Yasushi Inoue
    Munetoshi Nakashima
    Yutaro Yamasaki
    Hiroaki Niiro
    Yasuharu Nakashima
    Takuaki Yamamoto
    BMC Rheumatology, 8 (1)
  • [45] Efficacy and safety of fondaparinux in the initial treatment of venous thromboembolism (VTE) in patients with moderate renal impairment (MRI) Buller
    Buller, H. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 459 - 459
  • [46] Safety, Anti-Viral Efficacy and Pharmacokinetics (PK) of Sofosbuvir (SOF) in Patients with Severe Renal Impairment
    Gane, Edward J.
    Robson, Richard A.
    Bonacini, Maurizio
    Maliakkal, Benedict
    Liu, Lin
    Sajwani, Karim
    Stamm, Luisa M.
    Brainard, Diana M.
    McHutchison, John G.
    Stedman, Catherine A.
    Lawitz, Eric
    HEPATOLOGY, 2014, 60 : 667A - 667A
  • [47] The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study
    Atsukawa, Masanori
    Tsubota, Akihito
    Toyoda, Hidenori
    Takaguchi, Koichi
    Nakamuta, Makoto
    Watanabe, Tsunamasa
    Michitaka, Kojiro
    Ikegami, Tadashi
    Nozaki, Akito
    Uojima, Haruki
    Fukunishi, Shinya
    Genda, Takuya
    Abe, Hiroshi
    Hotta, Naoki
    Tsuji, Kunihiko
    Ogawa, Chikara
    Tachi, Yoshihiko
    Shima, Toshihide
    Shimada, Noritomo
    Kondo, Chisa
    Akahane, Takehiro
    Aizawa, Yoshio
    Tanaka, Yasuhito
    Kumada, Takashi
    Iwakiri, Katsuhiko
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (09) : 1230 - 1241
  • [48] Clinical Efficacy and Safety of Low-Dose Pemafibrate in Patients With Severe Renal Impairment: A Retrospective Study
    Shima, Hisato
    Tashiro, Manabu
    Inoue, Tomoko
    Okada, Kazuyoshi
    Okamoto, Takuya
    Wariishi, Seiichiro
    Doi, Toshio
    Minakuchi, Jun
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [49] Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment
    Newman, J.
    McGill, J. B.
    Patel, S.
    Friedrich, C.
    Sauce, C.
    Woerle, H. -J.
    DIABETOLOGIA, 2011, 54 : S333 - S333
  • [50] Risedronate in osteoporotic patients with renal impairment: A safety and efficacy analysis
    Boonen, S
    Miller, PD
    Barton, IP
    Dunlap, LE
    Burgi, DE
    Roux, C
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S52 - S53
12345